Melatonin protects against isoproterenol-induced alterations in cardiac mitochondrial energy-metabolizing enzymes, apoptotic proteins, and assists in complete recovery from myocardial injury in rats

Journal of Pineal Research

Volumn 53, Issue 2, 2012, Pages 166-179

  Mukherjee, Debasri ^a   Ghosh, Arnab K ^a   Bandyopadhyay, Arun ^b   Basu, Anjali ^a   Datta, Santanu ^c   Pattari, Sanjib K ^d   Reiter, Russel J ^e   Bandyopadhyay, Debasish ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^c INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^d Narayana Health   (India)

^e Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

antioxidant; heart function; isoproterenol; melatonin; myocardial injury; oxidative stress; tissue recovery

Indexed keywords

ACTIN; ALPHA ACTININ; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; ASPARTATE AMINOTRANSFERASE; CASPASE 9; CYTOCHROME C; CYTOCHROME C OXIDASE; GLUTATHIONE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; ISOCITRATE DEHYDROGENASE 2; ISOPRENALINE; LACTATE DEHYDROGENASE; MELATONIN; MITOCHONDRIAL ENZYME; MITOGEN ACTIVATED PROTEIN KINASE 1; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; STRESS ACTIVATED PROTEIN KINASE; SUCCINATE DEHYDROGENASE; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DAMAGE; CELL STRESS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; ENZYME BLOOD LEVEL; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE INJURY; HEART PROTECTION; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MALE; MORPHOLOGY; NONHUMAN; RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; GLUTATHIONE; ISOENZYMES; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; LIPID PEROXIDES; MALE; MELATONIN; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84864966191     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2012.00984.x     Document Type: Article

References (62)

1. Tengattini S, Reiter RJ, Tan DX, et al., Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008; 44: 16-25.
2. Reiter RJ, Tan DX,. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003; 58: 10-19.
3. Chattopadhyay A, Bandyopadhyay D,. Ischemic heart disease: protection by vitamin E. Pharmacol Rep 2006; 58: 179-187.
4. Peyrot F, Ducrocq C,. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008; 45: 235-244.
5. Bandyopadhyay D, Chattopadhyay A, Ghosh G, Datta AG,. Oxidative stress-induced ischemic heart disease: protection by antioxidants. Curr Med Chem 2004; 11: 369-387.
6. Mukherjee D, Roy SG, Bandyopadhyay A, et al., Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms. J Pineal Res 2010; 48: 251-262.
7. Chattopadhyay A, Biswas S, Bandyopadhyay D, Sarkar C, Datta AG,. Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine. Mol Cell Biochem 2003; 245: 43-49.
8. Hattori A, Migitaka H, Iigo M, et al., Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem Mol Biol Int 1999; 35: 327-334.
9. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ,. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28-42.
10. Tan DX, Hardeland R, Manchester LC, et al., The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness. Biol Rev 2010; 85: 607-623.
11. Reiter RJ, Paradies SO, Manchester LC, Tan DX,. Reducing oxidative/nitrosative stress: a newly discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44: 175-200.
12. 2+-mediated permeability transition and beyond in rat brain astrocytes. J Pineal Res 2010; 48: 20-38.
13. Paradies G, Petnosillo G, Paradies V, Reiter RJ, Ruggiero FM,. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-319.
14. Leon J, Acuna-Castroviejo D, Escames G, Tan DX, Reiter RJ,. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005; 38: 1-9.
15. Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S,. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann N Y Acad Sci 2001; 939: 200-215.
16. Oragicevi N, Copes N, O'neal-Moffit G, et al., Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling. J Pineal Res 2011; 51: 75-86.
17. Tan DX, Manchester LC, Reiter RJ, Qi W, Kim SJ, El-Sokkary GH,. Ischemia/reperfusion-induced arrhythmias in an isolated rat heart: prevention by melatonin. J Pineal Res 1998; 25: 184-191.
18. Ozturk M, Ozler M, Kurt YG, et al., Efficacy of melatonin in mercaptoethyl guanidine and 1800W in doxorubicin-and trastuzumab-induced cardiotoxicity. J Pineal Res 2011; 50: 89-96.
19. Forman K, Vara E, Garcia C, et al., Beneficial effects of melatonin on cardiological alterations in a murine model of accelerated aging. J Pineal Res 2010; 49: 312-320.
20. Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, et al., Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 2010; 49: 14-22.
21. Chretien D, Pourrier M, Bourgeron T, et al., An improved spectrophotometric assay of pyruvate dehydrogenase in lactate deheydrogenase contaminated mitochondrial preparations from human skeletal muscles. Clin Chem Acta 1995; 240: 129-136.
22. Duncan MJ, Fraenkel DG,. Alpha-ketoglutarate dehydrogenase mutant of Rhizobium meliloti. J Bacteriol 1979; 37: 415-419.
23. Veeger C, Vartanian DV, Zeylemaker WP,. Succinate dehydrogenase. Meth Enzymol 1969; 13: 81-90.
24. Goyal N, Srivastava VML,. Oxidation and reduction of cytochrome c by mitochondrial enzymes of Setaria cervi. J Helminth 1995; 69: 13-17.
25. Bandyopadhyay D, Ghosh G, Bandyopadhyay A, Reiter RJ,. Melatonin protects against piroxicam-induced gastric ulceration. J Pineal Res 2004; 36: 195-203.
26. Laemmli UK,. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 27: 680-685.
27. Strittmatter CF,. Studies on avian xanthine dehydrogenases: properties and patterns of appearance during development. J Biol Chem 1965; 240: 2557-2564.
28. Varcoe JS,. Clinical Biochemistry: Techniques and Instrumentation-A Practical Approach, 1st edn. World Scientific Publishing Company, Singapore, 2001.
29. Buege JA, Aust SD,. Microsomal lipid peroxidation. Meth Enzymol 1978; 52: 302-310.
30. Sedlak J, Lindsay RH,. Estimation of total protein bound and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25: 192-205.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ,. Protein measurement with Folin phenol reagent. J Biol Chem 1970; 193: 265-275.
32. Connelly KA, Prior DL, Kelly DJ, Feneley MP, Krum H, Gilbert RE,. Load-sensitive measures may overestimate global systolic function in the presence of left ventricular hypertrophy: a comparison with load-insensitive measures. Am J Physiol Heart Circ Physiol 2006; 290: H1699-H1705.
33. Ghose Roy S, De P, Mukherjee D, et al., Excess of glucocorticoid induces cardiac dysfunction via activating angiotensin II pathway. Cell Physiol Biochem 2009; 24: 1-10.
34. Noronha-Dutra AA, Steen EM, Woolf N,. The early changes induced by isoproterenol in the endocardium and adjacent myocardium. Am J Pathol 1984; 114: 231-239.
35. Lucchesi BR,. Modulation of leukocyte-mediated myocardial reperfusion injury. Annu Rev Physiol 1990; 52: 561.
36. Fariss MW, Chan CB, Patel M, et al., Role of mitochondria in toxic oxidative stress. Mol Interv 2005; 5: 94-111.
37. Wallace DC,. A mitochondrial paradigm of metabolic and degenerative diseases, and aging: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39: 359-407.
38. Martin M, Macias M, Leon J, Escames G, Khaldy H, Acuna-Castroviejo D,. Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol 2002; 34: 348-357.
39. Reiter RJ, Tan DX, Manchester LC, El-Sawi MR,. Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann N Y Acad Sci 2002; 959: 238-250.
40. Zamzami N, Larochetti N, Kroemer G,. Mitochondrial permeability transition in apoptosis and necrosis. Cell Death Differ 2005; 12: 1478-1480.
41. Leon J, Acuna-Castroviejo D, Sainz RM, et al., Melatonin and mitochondrial function. Life Sci 2004; 75: 765-790.
42. Luchetti F, Betti M, Canonico B, et al., ERK MAPK activation mediates the antiapoptotic signaling of melatonin inUVB-stressed U937 cells. Free Radic Biol Med 2009; 46: 339-351.
43. Radogna F, Cristofanon S, Paternoster L, et al., Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2. J Pineal Res 2008; 44: 316-325.
44. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
45. Acuna-Castroviejo D, Escames G, Rodriguez MI, Lopez LC,. Melatonin role in the mitochondrial function. Front Biosci 2007; 12: 947-963.
46. Zhang GX, Kimura S, Nishiyama A,. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res 2005; 65: 230-238.
47. Li C, Jackson RM,. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002; 282: 227-241.
48. Singal PK, Kapur N, Dhillon KS, Beamish RE, Dhalla NS,. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 1982; 60: 1390-1397.
49. 3+ induced neurotoxicity of dopamine. prevention of quinine-derived oxygen toxicity of DT diaphorase and superoxide dismutase. Chem Biol Interact 1989; 72: 309-324.
50. Winiarska K, Fraczy KT, Malinska O, Drozak J, Bryla J,. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J Pineal Res 2006; 40: 168-176.
51. Reiter RJ, Tan DX, Sainz RM, Mayo JC,. Melatonin protects the heart against both ischemia/reperfusion injury and chemotherapeutic drugs. Cardiovasc Drugs Ther 2002; 16: 5-6.
52. Kaneko S, Okumura K, Numaguchi Y, et al., Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury. Life Sci 2000; 67: 101-112.
53. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Reiter RJ,. Relation of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction. Thromb Res 2007; 120: 361-366.
54. Bertuglia S, Reiter RJ,. Melatonin reduces ventricular arrhythmias and preserves capillary perfusion during ischemia-reperfusion events in cardiomyopathic hamsters. J Pineal Res 2007; 42: 55-63.
55. Korkmaz AA, Reiter RJ, Topal T, et al., Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 2009; 15: 43-50.
56. Reiter RJ, Tan DX,. Melatonin and cardiac pathophysiology. Heart Metab 2009; 44: 31-34.
57. Tan DX, Chen LD, Poeggeler B, et al., Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
58. Hardeland R, Tan DX, Reiter RJ,. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
59. Reiter RJ, Korkmaz A,. Clinical aspects of melatonin. Saudi Med J 2008; 29: 1537-1547.
60. Reiter RJ, Tan DX, Sainz RM, et al., Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 2002; 54: 1299-1321.
61. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia Gonzalez MJ, et al., A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of melatonin as an adjunct in patients with acute myocardial infarction undergoing primary angioplasty-the melatonin adjunct in the acute myocardial infarction treated with angioplasty (MARIA) trial: study design and rationale. Contemp Clin Trials 2007; 28: 532-539.
62. Bandyopadhyay D, Chattopadhyay A,. Reactive oxygen species-induced gastric ulceration: protection by melatonin. Curr Med Chem 2006; 13: 1187-1202.